ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$25.55
-1.45 (-5.37%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+235.7% upside
Low Target
$74.20
Average Target
$85.78
High Target
$112.10
Current Price
$25.55
Current
$25.55
$25.55
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Scenario Analysis
Bear Case
$74.20
190.4%
Low target
Base Case
$85.78
+235.7%
Avg target
Bull Case
$112.10
+338.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$34.80
-26.6% from high
52-Week Low
$19.30
+32.4% from low
50-Day SMA
$27.16
-5.9% vs SMA
200-Day SMA
$25.34
+0.8% vs SMA
RSI (14)
31.2
Neutral
Target vs 52W High
$85.78
+146.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |